English   español  

Navegación por Autor Lacal, Juan Carlos

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 39 a 53 de 53 < Anterior 
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
closedAccessaccesoRestringido.pdf.jpg1993Phosphorylcholine: A novel second messenger essential for mitogenic activity of growth factorsCuadrado, Antonio CSIC ORCID; Carnero, Amancio CSIC ORCID; Dolfi, F.; Jiménez, Benilde CSIC; Lacal, Juan Carlos CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2013Protein arrays: recent achievements and their application to study the human proteomeCasado-Vela, Juan CSIC ORCID CVN; González González, María; Matarraz, Sergio; Sayagués, José María CSIC ORCID ; Fuentes, Manuel CSIC ORCID ; Lacal, Juan Carlos CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2013Protein chimerism: Novel source of protein diversity in humans adds complexity to bottom-up proteomicsCasado-Vela, Juan CSIC ORCID CVN; Lacal, Juan Carlos CSIC ORCID; Elortza, Felixartículo
openAccess1476-4598-8-131.pdf.jpgdic-2009Regulation of Akt (ser473) phosphorylation by Choline kinase in breast carcinoma cellsTin Chua, Boon; Gallego Ortega, David CSIC ORCID; Ramírez de Molina, Ana CSIC ORCID; Ullrich, Axel; Lacal, Juan Carlos CSIC ORCID; Downward, Julianartículo
closedAccessaccesoRestringido.pdf.jpg1990Regulation of protein kinase C activity in neuronal differentiation induced by the N-ras oncogene in PC-12 cellsLacal, Juan Carlos CSIC ORCID; Cuadrado, Antonio CSIC ORCIDartículo
openAccessRho GTPase Rac1.pdf.jpg2014Rho GTPase Rac1: Molecular switch within the galectin network and for N-Glycan α2,6‑sialylation/O-glycan core 1 sialylation in colon cancer in vitroAndré, Sabine; Singh, T.; Lacal, Juan Carlos CSIC ORCID; Smetana Jr., K.; Gabius, Hans-Joachimartículo
openAccessRho GTPases.pdf.jpg2003Rho GTPases in human carcinogenesis: A tale of excessAznar, Salvador CSIC ORCID; Espina, Carolina CSIC; Valerón, Pilar F.; Lacal, Juan Carlos CSIC ORCIDartículo
openAccess3041.pdf.jpgjul-2003ROCK and nuclear factor-{kappa}B–dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequencesAznar, Salvador CSIC ORCID; Valerón, Pilar F.; Lacal, Juan Carlos CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2001Searching new targets for anticancer drug design: The families of Ras and Rho GTPases and their effectorsAznar, Salvador CSIC ORCID; Lacal, Juan Carlos CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2012Sensitization of (colon) cancer cells to death receptor related therapies. A report from the FP6-ONCODEATH research consortiumPintzas, Alexander; Lacal, Juan Carlos CSIC ORCID; Andera, Ladislavartículo
openAccessSimultaneous tyrosine.pdf.jpgoct-2001Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformationAznar, Salvador CSIC ORCID; Valerón, Pilar F.; Rincón, Sonia Victoria del; Fernández-Pérez, Leandro CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Lacal, Juan Carlos CSIC ORCIDartículo
openAccessSTAT5a.pdf.jpgene-2003STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoAAznar, Salvador CSIC ORCID; Valerón, Pilar F.; Rui, Hallgeir; Lacal, Juan Carlos CSIC ORCIDartículo
openAccessWO0012755A1.pdf.jpg9-mar-2000System for screening compounds with antitumoral, antiviral, antiparasit and antifungal activityLacal, Juan Carlos CSIC ORCIDpatente
closedAccessaccesoRestringido.pdf.jpg2000The Ras family of GTPases in cancer cell invasionHernández-Alcoceba, Rubén; Peso, Luis del CSIC ORCID; Lacal, Juan Carlos CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2012Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic targetCasado, Enrique CSIC; Gómez del Pulgar, Teresa CSIC; Belda-Iniesta, Cristobal; Lacal, Juan Carlos CSIC ORCID; Cejas, Palomaartículo